abstract |
The present application discloses novel substituted naphthyridine derivatives of Formula (I) and their use as modulators of the voltage gated K v 7 (KCNQ) potassium ion channels. In other aspects the application discloses the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising these compounds. |